PedAM
Pediatric Disease Annotations & Medicines
| Disease | vascular disease |
| Phenotype | |metabolic syndrome |
| Sentences | 99 |
| PubMedID- 22046877 | metabolic syndrome promotes development of atherosclerotic cardiovascular disease related to abdominal type obesity and insulin resistance. |
| PubMedID- 20031349 | The metabolic syndrome: validity and utility of clinical definitions for cardiovascular disease and diabetes risk prediction. |
| PubMedID- 21747838 | Studies have shown increased risk for cardiovascular disease and mortality in patients with metabolic syndrome [21]. |
| PubMedID- 23438154 | Background: metabolic syndrome is a cluster of risk factors for cardiovascular disease and type 2 diabetes. |
| PubMedID- 23974905 | Therefore, rd may be a useful therapeutic strategy for cardiovascular diseases in hypertension with metabolic syndrome. |
| PubMedID- 23873328 | Background and aims: metabolic syndrome (ms) leads to excess cardiovascular disease, including heart failure. |
| PubMedID- 23968387 | Recent studies have called attention to a role for epicardial adipose tissue (eat) inflammation as an additional determinant of inflammation and susceptibility to cardiovascular disease in patients with obesity and metabolic syndrome [3]. |
| PubMedID- 25857370 | Background and purpose: increased level of very low-density lipoprotein (vldl) is a key feature of the metabolic syndrome and is associated with cardiovascular diseases. |
| PubMedID- 20940070 | Analysis results on population attributable risks showed that about a quarter of total diabetes occurrence and more than 10% of cardiovascular disease was attributable to the metabolic syndrome. |
| PubMedID- 20972515 | The world heart federation stated in 2006 that obesity is associated with type 2 diabetes, hypertension and the metabolic syndrome (ms), all of which cause cardiovascular disease (cvd).1 as obesity is on the increase in south africa, especially in urban areas, with up to 45% of the population already overweight, the prevalence of the ms is increasing.2 the thusa study (transition and health during urbanisation in south africa) revealed a greater prevalence of cvd and ms indicators in urban black south africans (hereafter referred to as africans).3 furthermore, malan et al.3-5 revealed that urban african men utilising an active coping (ac) style were at an increased risk for hypertension, the ms and increased blood glucose values. |
| PubMedID- 20967757 | Plasma c-reactive protein (crp) concentration is increased in the metabolic syndrome, which consists of a cluster of cardiovascular disease risk factors, including insulin resistance. |
| PubMedID- 20689417 | Recent findings: individuals infected with hiv frequently demonstrate a metabolic syndrome associated with atherosclerosis and cardiovascular disease. |
| PubMedID- 24233518 | The authors cite other published studies that suggest that co-morbidities within the african-american population, such as a metabolic syndrome of cardiovascular disease and diabetes, might account for increased risk for cognitive impairment independent of hiv infection. |
| PubMedID- 25436098 | Increased body fat accompanied with diabetes mellitus, hypertension or changes in lipid metabolism, which is considered a separate disease as “metabolic syndrome” increases risk of cardiovascular diseases (5). |
| PubMedID- 20488778 | In any case, the results of the present study suggest that the endocrine disruptor bpa should be evaluated as a possible risk factor for gestational diabetes, type 2 diabetes, and cardiovascular disease associated with metabolic syndrome. |
| PubMedID- 24383894 | The assessment of the carotid circulation through doppler ultrasound in subjects free of cardiovascular disease, with and without metabolic syndrome (ms) showed that incidence of cardiovascular events (myocardial infarction, transient ischemic attack, abdominal aortic aneurysm, and thrombo-endo-arterectomy) in a 20-year follow-up was higher among subjects aged 62 ± 12 years old with metabolic syndrome (mets), and the incidence increased whenever there was presence of preclinical carotid atherosclerosis [40]. |
| PubMedID- 21841320 | Objective: the aim of this study was to evaluate the effects of health checkup and the health education "hokenshido" program based on the concept that visceral fat accumulation causes metabolic syndrome (mets), leading to cardiovascular disease (cvd). |
| PubMedID- 26089614 | Abdominal obesity (ao) and metabolic syndrome (mets) are associated with the cardiovascular disease and type 2 diabetes. |
| PubMedID- 25247821 | These findings have important public health implications due to the known cardiovascular disease risk factors associated with metabolic syndrome. |
| PubMedID- 20509277 | Aim: to analyze the components of metabolic syndrome from patients with cardiovascular disease (myocardial infarction). |
| PubMedID- 19931306 | Obesity and metabolic syndrome, with increased risk of eventual cardiovascular disease and type ii diabetes, are significant problems for patients receiving antipsychotic drugs and are likely contribute to their decreased life expectancy. |
| PubMedID- 22766701 | Hypertension, hypercoagulability and the metabolic syndrome: a cluster of risk factors for cardiovascular disease. |
| PubMedID- 22433747 | Dairy products may have potentially advantageous effects on other metabolic risk factors via beneficial effects on blood pressure [22-24], type 2 diabetes [25,26] and the metabolic syndrome [22,27-31], all of which are cardiovascular disease (cvd) risk factors. |
| PubMedID- 22717638 | The metabolic syndrome, a cluster of risk factors for cardiovascular disease, is closely related to environmental and lifestyle risk factors. |
| PubMedID- 23756586 | Objectives: metabolic syndrome is a precursor of diabetes and cardiovascular disease (cvd). |
| PubMedID- 24856006 | Objectives since oils and fats can induce metabolic syndrome, leading to cardiovascular and cerebrovascular diseases, the present study was performed to find out whether the plant oils affect the cerebral hemorrhage in stroke-prone spontaneously hypertensive (shr-sp) rats. |
| PubMedID- 22950955 | The metabolic syndrome is a constellation of risk factors for cardiovascular diseases including: abdominal obesity, a decreased ability to metabolize glucose (increased blood glucose levels and/or presence of insulin resistance), dyslipidemia, and hypertension. |
| PubMedID- 21766575 | [the association of cardiovascular disease with metabolic syndrome and its risk factors in japanese urban cohort: the suita study]. |
| PubMedID- 20004035 | Aims: to compare the cardiovascular disease (cvd) risk associated with the metabolic syndrome (mets) and dysglycemia, independent of each other during a median follow-up of 6.7 years. |
| PubMedID- 26485682 | Sympathetic abnormalities play an important role in the pathophysiology of cardiovascular disease associated with metabolic syndrome, diabetes mellitus and obesity [1–4]. |
| PubMedID- 21932717 | metabolic syndrome is a cluster of risk factors for cardiovascular disease that affects an estimated 50 million americans. |
| PubMedID- 23257741 | [chronic cerebrovascular diseases associated with metabolic syndrome: new treatment approaches]. |
| PubMedID- 22417140 | Recent research has begun to elucidate the effects of hypothalamic inflammation in causing diverse components of metabolic syndrome leading to diabetes and cardiovascular disease. |
| PubMedID- 23718264 | Badjusting for self-perceived sami ethnicity, smoking, leisure-time light physical activity, metabolic syndrome, family history of cardiovascular disease, education, sex and age. |
| PubMedID- 22314111 | metabolic syndrome increases the risk of developing cardiovascular disease and type 2 diabetes mellitus. |
| PubMedID- 24708775 | In clinical trials, bezafibrate has been highly effective at reducing cardiovascular disease risk in patients with metabolic syndrome or atherogenic dyslipidemia [32,37]. |
| PubMedID- 25916279 | Conclusions: fetuin-a has a diagnostic potential as a biomarker for liver dysfunction, cardiovascular diseases and disorders associated with metabolic syndrome. |
| PubMedID- 22737524 | Background: the metabolic syndrome (mets) consists of major clustering of cardiovascular disease (cvd) risk factors. |
| PubMedID- 22424625 | Objective: the association of metabolic syndrome (mets) with cardiovascular diseases (cvd) has not been adequately explored in middle-aged and elderly chinese. |
| PubMedID- 26491696 | In particular, sodium reabsorption is regulated by various transporters along the nephron and to elucidate the mechanism of its regulation is important because excess renal sodium retention causes hypertension in metabolic syndrome that leads to cardiovascular disease [1]. |
| PubMedID- 23781121 | These new observations suggest that agonists for par-β/-δ may be effective agents to reverse cholesterol deposition in foam cells in atherotic lesions and therefore decrease cardiovascular disease associated with the metabolic syndrome. |
| PubMedID- 20300596 | Depression is an independent risk factor for cardiovascular diseases and is associated with metabolic syndrome (mets). |
| PubMedID- 20671994 | On the other hand, no clinical trial evidence indicates that these drugs will reduce risk for cardiovascular disease events in patients with the metabolic syndrome. |
| PubMedID- 23130323 | Therefore, people with a high basal c-peptide level need to decrease it to reduce the risk of coronary heart disease and cerebral vascular disease associated with metabolic syndrome. |
| PubMedID- 24676221 | Background: subclinical cardiovascular disease is prevalent in patients with metabolic syndrome (metsyn). |
| PubMedID- 26055571 | metabolic syndrome increases the risk of developing diabetes and cardiovascular disease, particularly heart failure. |
| PubMedID- 22666231 | S. devaraj and i. jialal report how number and/or functionality of endothelial progenitor cells (epcs) could emerge as a novel cellular biomarker of endothelial/vascular dysfunction and cardiovascular disease (cvd) risk in patients with the metabolic syndrome. |
| PubMedID- 24498934 | Relation between ev-markers and metabolic syndrome in patients with manifest cardiovascular disease. |
| PubMedID- 25918936 | The molecular processes that occur in metabolic syndrome can lead to cardiovascular disease pathogenesis and involve risk factors such as oxidative stress and inflammation [2,5]. |
Page: 1 2